Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Sanofi-Aventis, Roche Sign Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Sanofi-Aventis, Roche Sign Pact

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sanofi-Aventis has signed an agreement with Roche concerning the production of shikimic acid by fermentation for Roche’s Tamiflu supply chain. Shikimic acid is the key raw material for the manufacture of Tamiflu’s active ingredient (oseltamivir). Under the terms of the agreement, Sanofi-Aventis will supply Roche exclusively with the shikimic acid obtained. The shikimic acid will be produced in the Saint-Aubin-les-Elbeuf plant in France. This site, covering 18 hectares, has a fermentation capacity of 4000 m(3), and employs 270 staff.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics